Chelsy Binkley
Family · Lincoln, NENPI 1043702293
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,732 of the $4,236 with a category attached, or 64.5%. 23 manufacturers reported payments, led by Boston Scientific at 55.9% of the total. 2025 is the largest year on record at $2,700, more than ten times the $70 reported in 2021. Among family clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $33.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- AbbVie$1K
- Novo Nordisk$81
- Pfizer$50
- Abbott$45
- Biohaven Pharmaceutical Holding Company Ltd.$45
- plus $426 from 17 others
What the payments were for
- Travel & lodging$1,50335%
- Food & beverage$2,73265%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $2,369 |
| AbbVie | 69 | $1,220 |
| Novo Nordisk | 5 | $81 |
| Pfizer | 3 | $50 |
| Abbott | 2 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $45 |
| SPR Therapeutics, Inc | 1 | $43 |
| Merck | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Mylan Specialty L.p. | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Lundbeck LLC | 1 | $26 |
| AstraZeneca | 2 | $25 |
| Novartis | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| Bioventus LLC | 1 | $20 |
| Bayer | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Amgen | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,236 in reported general payments places this provider in the 95th percentile of 809 family providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $700 |
| Estradiol | 12 | $470 |
| Methocarbamol | 14 | $428 |
| Cefdinir | 23 | $421 |
| Omeprazole | 27 | $376 |
| Gabapentin | 36 | $371 |
| Cyclobenzaprine Hcl | 16 | $263 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $259 |
| Fluticasone Propionate | 19 | $250 |
| Rosuvastatin Calcium | 28 | $240 |
| Doxycycline Hyclate | 22 | $213 |
| Hydroxychloroquine Sulfate | 11 | $192 |
| Escitalopram Oxalate | 16 | $185 |
| Metoprolol Succinate | 29 | $173 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $167 |
Paid to pharmacies, not to this prescriber.
Other family in Lincoln
- Mary MetzLincoln$13K
- Alyson FergusonLincoln$7K
- Mary GladeLincoln$7K
- Colleen CarpenterLincoln$5K
- Melany MurrayLincoln$5K
- Samantha NiceLincoln$5K
- Miranda PollmanLincoln$5K
- Marissa EbelLincoln$5K
- John GrandgenettLincoln$4K
- Lori MalloryLincoln$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.